Literature DB >> 22532175

Breast cancer mortality in Norway after the introduction of mammography screening.

Anne Helene Olsen1, Elsebeth Lynge, Sisse H Njor, Merethe Kumle, Marit Waaseth, Tonje Braaten, Eiliv Lund.   

Abstract

An organized mammography screening program was gradually implemented in Norway during the period 1996-2004. Norwegian authorities have initiated an evaluation of the program. Our study focused on breast cancer mortality. Using Poisson regression, we compared the change in breast cancer mortality from before to during screening in four counties starting the program early controlling for change in breast cancer mortality during the same time in counties starting the program late. A follow-up model included death in all breast cancers diagnosed during the follow-up period. An evaluation model included only breast cancers diagnosed in ages where screening was offered. The study group had been invited for screening one to three times and followed for on average of 5.9 years. In the follow-up model, 314 breast cancer deaths were observed in the study group, and 523, 404 and 638, respectively, in the four control groups. The ratio between the changes in breast cancer mortality between early and late starting counties was 0.93 (95% confidence interval [CI] 0.77-1.12). In the evaluation model, this ratio was 0.89 (95% CI: 0.71-1.12). In Norway, where 40% of women used regular mammography prior to the program, the implementation of the organized mammography screening program was associated with a statistically nonsignificant decrease in breast cancer mortality of around 11%.
Copyright © 2012 UICC.

Entities:  

Mesh:

Year:  2012        PMID: 22532175     DOI: 10.1002/ijc.27609

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

1.  Breast cancer screening: evidence of benefit depends on the method used.

Authors:  Philippe Autier; Mathieu Boniol
Journal:  BMC Med       Date:  2012-12-12       Impact factor: 8.775

2.  Breast cancer mortality gaps in Romanian women compared to the EU after 10 years of accession: Is breast cancer screening a priority for action in Romania? (Review of the Statistics).

Authors:  Florentina Furtunescu; Roxana Elena Bohiltea; Silviu Voinea; Tiberiu Augustin Georgescu; Octavian Munteanu; Adrian Neacsu; Corina Silvia Pop
Journal:  Exp Ther Med       Date:  2021-01-25       Impact factor: 2.447

3.  Modern mammography screening and breast cancer mortality: population study.

Authors:  Harald Weedon-Fekjær; Pål R Romundstad; Lars J Vatten
Journal:  BMJ       Date:  2014-06-17

4.  Conclusions for mammography screening after 25-year follow-up of the Canadian National Breast Cancer Screening Study (CNBSS).

Authors:  S H Heywang-Köbrunner; I Schreer; A Hacker; M R Noftz; A Katalinic
Journal:  Eur Radiol       Date:  2015-05-28       Impact factor: 5.315

5.  Screening by Clinical Breast Examination in Western Kenya: Who Comes?

Authors:  Naftali Wisindi Busakhala; Fredrick Asirwa Chite; Juddy Wachira; Violet Naanyu; Job Wapangana Kisuya; Alfred Keter; Ann Mwangi; Evanjeline Njiru; David Chumba; Lugaria Lumarai; Penina Biwott; Ivan Kiplimo; Grieven Otieno; Gabriel Kigen; Patrick Loehrer; Thomus Inui
Journal:  J Glob Oncol       Date:  2016-01-27

6.  Screening mammography & breast cancer mortality: meta-analysis of quasi-experimental studies.

Authors:  Veronica L Irvin; Robert M Kaplan
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

7.  The association between lifetime smoking exposure and breast cancer mortality--results from a Norwegian cohort.

Authors:  Eivind Bjerkaas; Ranjan Parajuli; Anders Engeland; Gertraud Maskarinec; Elisabete Weiderpass; Inger Torhild Gram
Journal:  Cancer Med       Date:  2014-07-30       Impact factor: 4.452

8.  Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program.

Authors:  Solveig Hofvind; Giske Ursin; Steinar Tretli; Sofie Sebuødegård; Bjørn Møller
Journal:  Cancer       Date:  2013-05-29       Impact factor: 6.860

9.  Distinct Small RNA Signatures in Extracellular Vesicles Derived from Breast Cancer Cell Lines.

Authors:  Tonje Fiskaa; Erik Knutsen; Marlen Aas Nikolaisen; Tor Erik Jørgensen; Steinar Daae Johansen; Maria Perander; Ole Morten Seternes
Journal:  PLoS One       Date:  2016-08-31       Impact factor: 3.240

10.  The impacts of public mammography screening on the relationship between socioeconomic status and cancer stage.

Authors:  Søren T Klitkou
Journal:  SSM Popul Health       Date:  2016-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.